← Insider buys

GDRX

GoodRx Holdings, Inc. · Healthcare

Insiders sold $9.7M of GoodRx Holdings, Inc. in the last 12 months and bought none

$0Bought, 12 mo
$9.7MSold, 12 mo
$1.2BMarket cap

GDRX over the last year

No insider buys filed in this year

GDRX after insider buys

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

83 insider filings since 2020, newest first

GDRXSell

FRANCISCO PARTNERS IV, L.P. · 10% owner

$5.5M−100.0%Aug 27
GDRXSell

FRANCISCO PARTNERS IV, L.P. · 10% owner

$4.2M−60.6%Aug 22
GDRXSell

Spectrum Equity Vii, L.P. · 10% owner

$84K−100.0%Sep 3
GDRXSell

Romin Nabiey · Chief Accounting Officer

$535K−55.0%Aug 14
GDRXBuy

Scott Wagner · Insider

$125K+13.0%Dec 4
GDRXSell

Idea Men, LLC · 10% owner

$86K−100.0%Jan 5
GDRXSell

Andrew Slutsky · Pres, Consumer

$1.2M−1.0%Jan 4
GDRXSell

Karsten Voermann · CFO

$413K−100.0%Dec 30
GDRXSell

Trevor Bezdek · Co-CEO

$4.5M−50.0%Dec 23
GDRXSell

Abdiel Capital Management, LLC · 10% owner

$7.0M−1.0%Dec 22
GDRXSell

Abdiel Capital Management, LLC · 10% owner

$18.3M−3.0%Dec 17
GDRXSell

Douglas Joseph Hirsch · Co-CEO

$4.8M−50.0%Dec 17
GDRXSell

Babak Azad · Insider

$523K−71.0%Dec 13
GDRXSell

Andrew Slutsky · Pres, Consumer

$6.8M−5.0%Dec 10
GDRXSell

Idea Men, LLC · 10% owner

$19.7M−100.0%Dec 3
GDRXSell

Karsten Voermann · CFO

$493K−100.0%Dec 3
GDRXSell

Babak Azad · Insider

$528K−100.0%Nov 12
GDRXSell

Karsten Voermann · CFO

$542K−100.0%Nov 3
GDRXSell

Idea Men, LLC · 10% owner

$13.7M−100.0%Nov 3
GDRXSell

Andrew Slutsky · Pres, Consumer

$935K−1.0%Oct 26
GDRXSell

Bansi Nagji · Pres, Healthcare

$738K−100.0%Oct 21
GDRXSell

Babak Azad · Insider

$307K−100.0%Oct 13
GDRXSell

Bansi Nagji · Pres, Healthcare

$162K−11.0%Oct 12
GDRXSell

Idea Men, LLC · 10% owner

$6.9M−100.0%Oct 4
GDRXSell

Andrew Slutsky · Pres, Consumer

$1.5M−1.0%Oct 4
GDRXSell

Karsten Voermann · CFO

$302K−100.0%Sep 29
GDRXSell

Idea Men, LLC · 10% owner

$36.3M−100.0%Sep 29
GDRXSell

Douglas Joseph Hirsch · Co-CEO

$5.7M−50.0%Sep 28
GDRXSell

Trevor Bezdek · Co-CEO

$5.7M−50.0%Sep 28
GDRXSell

Andrew Slutsky · Pres, Consumer

$915K−1.0%Sep 23
GDRXSell

Andrew Slutsky · Pres, Consumer

$1.1M−1.0%Sep 16
GDRXSell

Agnes Rey-Giraud · Director

$1.1M−100.0%Sep 16
GDRXSell

Bansi Nagji · Pres, Healthcare

$8.1M−100.0%Sep 16
GDRXSell

Babak Azad · Insider

$524K−100.0%Sep 14
GDRXBuy

Abdiel Capital Management, LLC · 10% owner

$160KSep 13
GDRXSell

Agnes Rey-Giraud · Director

$2.3M−100.0%Sep 9
GDRXBuy

Abdiel Capital Management, LLC · 10% owner

$19.5M+3.0%Sep 8
GDRXBuy

Abdiel Capital Management, LLC · 10% owner

$26.4M+4.0%Sep 2
GDRXSell

Karsten Voermann · CFO

$463K−100.0%Sep 1
GDRXSell

Andrew Slutsky · Pres, Consumer

$667K−1.0%Aug 25
GDRXSell

Babak Azad · Insider

$207K−100.0%Aug 16
GDRXSell

Andrew Slutsky · Pres, Consumer

$195KAug 16
GDRXSell

Babak Azad · Insider

$196K−100.0%Aug 11
GDRXSell

Andrew Slutsky · Pres, Consumer

$26KAug 3
GDRXSell

Andrew Slutsky · Pres, Consumer

$439KJul 30
GDRXSell

Karsten Voermann · CFO

$409K−100.0%Jul 30
GDRXSell

Babak Azad · Insider

$412K−100.0%Jul 12
GDRXSell

Idea Men, LLC · 10% owner

$13.2M−100.0%Jul 9
GDRXSell

Idea Men, LLC · 10% owner

$17.7M−100.0%Jul 7
GDRXSell

Idea Men, LLC · 10% owner

$18.6M−100.0%Jul 2
About GoodRx Holdings, Inc.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.